Tianjin Chase Sun Pharmaceutical Co.,Ltd held its Annual General Meeting of 2021 on 21 April 2022 approved the profit distribution proposal for 2021 as cash dividend/10 shares (tax included): CNY 0.40000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.86 CNY | +1.58% | +4.61% | -8.96% |
03-29 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023 | CI |
03-01 | Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.96% | 1.6B | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
+39.87% | 1.45B |
- Stock Market
- Equities
- 300026 Stock
- News Tianjin Chase Sun Pharmaceutical Co.,Ltd
- Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021